Literature DB >> 27265407

Drug-resistant epilepsy in adults: Outcome trajectories after failure of two medications.

Hyunmi Choi1, Matthew J Hayat2, Ruiqi Zhang3, Lawrence J Hirsch4, Carl W Bazil1, Anil Mendiratta1, Kenneth Kato1, Asif Javed1, Alexander W Legge1, Richard Buchsbaum5, Stanley Resor5, Gary A Heiman6.   

Abstract

OBJECTIVE: To examine the seizure trajectories of adults with epilepsy developing drug-resistant epilepsy (DRE) and to identify the predictors of seizure trajectory outcome.
METHODS: Adult patients failing two antiepileptic drugs (AEDs) due to inefficacy and starting their third AED at a tertiary epilepsy center were followed for seizure trajectory outcome during medical management. Seizure trajectories were categorized into one of four patterns: (1) course with constant seizures; (2) fluctuating course; (3) delayed attainment of seizure freedom (seizure freedom delayed for >12 months after start of the study, but patient stayed in seizure freedom); and (4) early attainment of seizure freedom (within 12 months of starting study). Multiple ordinal logistic regression models were used to estimate the association between trajectory categories and clinical factors.
RESULTS: Four hundred three adult patients met the eligibility criteria. Of these, 212 (53%) never achieved a seizure-free period of a year or more. The trajectories of 63 patients (16%) had a complex fluctuating trajectory, 62 (15%) had delayed onset of seizure freedom, and 66 (16%) had an early seizure freedom. Independent predictors associated with more favorable outcome trajectories were epilepsy type and length of follow-up. Specifically, compared to patients with focal epilepsy of temporal lobe, patients with focal epilepsy of occipital lobe (OR 3.80, 95% confidence interval [CI] 1.00-14.51, p = 0.04), generalized genetic (OR 3.23, 95% CI 1.88-5.57, p < 0.0001), unclear epilepsy type (OR 3.82, 95% CI 1.53-9.52, p < 0.005), and both focal and generalized epilepsy(OR 11.73, 95% CI 1.69-81.34, p = 0.01) were significantly more likely to experience a better trajectory pattern. SIGNIFICANCE: Examination of patterns of seizure trajectory of patients with incident DRE showed that 31% were in continuous seizure freedom at the end of the observation period. Wiley Periodicals, Inc.
© 2016 International League Against Epilepsy.

Entities:  

Keywords:  All epilepsy/seizures; Antiepileptic drugs; Incidence studies; Prognosis

Mesh:

Substances:

Year:  2016        PMID: 27265407     DOI: 10.1111/epi.13406

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

1.  Drug-Resistant Epilepsy: Is it Really Sometimes RRMS (Relapsing-Remitting Multiple Seizures)?

Authors:  David Spencer
Journal:  Epilepsy Curr       Date:  2017 Jan-Feb       Impact factor: 7.500

2.  d-Leucine: Evaluation in an epilepsy model.

Authors:  Kylie Holden; Adam L Hartman
Journal:  Epilepsy Behav       Date:  2017-11-07       Impact factor: 2.937

3.  Continued medical management of drug-resistant epilepsy: implications for surgical consideration.

Authors:  Dario J Englot
Journal:  Epilepsia       Date:  2016-09       Impact factor: 5.864

Review 4.  Different Prognostic Patterns in Epilepsies and Considerations About the Denotations of Atypical Patterns.

Authors:  Arife Çimen Atalar; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2022-01-31       Impact factor: 1.339

5.  Alterations in the metabolic networks of temporal lobe epilepsy patients: A graph theoretical analysis using FDG-PET.

Authors:  Hye-Kyung Shim; Ho-Joon Lee; Sung Eun Kim; Byung In Lee; Seongho Park; Kang Min Park
Journal:  Neuroimage Clin       Date:  2020-07-15       Impact factor: 4.881

6.  6 Hz Active Anticonvulsant Fluorinated N-Benzamide Enaminones and Their Inhibitory Neuronal Activity.

Authors:  Isis J Amaye; Thomas Heinbockel; Julia Woods; Zejun Wang; Miguel Martin-Caraballo; Patrice Jackson-Ayotunde
Journal:  Int J Environ Res Public Health       Date:  2018-08-20       Impact factor: 3.390

Review 7.  Antiepileptic Drug Therapy in Patients with Drug-Resistant Epilepsy.

Authors:  Kang Min Park; Sung Eun Kim; Byung In Lee
Journal:  J Epilepsy Res       Date:  2019-06-30

8.  ABCB1 Polymorphisms and Drug-Resistant Epilepsy in a Tunisian Population.

Authors:  Malek Chouchi; Hedia Klaa; Ilhem Ben-Youssef Turki; Lamia Hila
Journal:  Dis Markers       Date:  2019-12-02       Impact factor: 3.434

Review 9.  Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances.

Authors:  Aaron M Farrelly; Styliani Vlachou; Konstantinos Grintzalis
Journal:  Int J Environ Res Public Health       Date:  2021-04-10       Impact factor: 3.390

10.  Genetic generalized and focal epilepsy prevalence in the North American SUDEP Registry.

Authors:  Chloe Verducci; Daniel Friedman; Elizabeth Donner; Orrin Devinsky
Journal:  Neurology       Date:  2020-03-26       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.